Metabolomic Characterization of Newest Designer Drugs

Authors

  • Tímea Körmöczi Institute of Pharmaceutical Analysis, University of Szeged, Somogyi street 4, H-6720, Szeged, Hungary
  • Petra Kovács Institute of Pharmaceutical Analysis, University of Szeged, Somogyi street 4, H-6720, Szeged, Hungary
  • Éva Sija Department of Forensic Medicine, University of Szeged, Kossuth L. Sgt. 40, H-6724, Szeged, Hungary
  • László Institóris Department of Forensic Medicine, University of Szeged, Kossuth L. Sgt. 40, H-6724, Szeged, Hungary
  • Éva Kereszty Department of Forensic Medicine, University of Szeged, Kossuth L. Sgt. 40, H-6724, Szeged, Hungary
  • István Ilisz Institute of Pharmaceutical Analysis, University of Szeged, Somogyi street 4, H-6720, Szeged, Hungary
  • Róbert Berkecz Institute of Pharmaceutical Analysis, University of Szeged, Somogyi street 4, H-6720, Szeged, Hungary

DOI:

https://doi.org/10.33892/aph.2021.91.185-186

Keywords:

Synthetic cannabinoids, metabolites, human liver microsome, urine samples, LC-MS/MS

Published

2021-11-15

How to Cite

(1)
Körmöczi, T.; Kovács, P.; Sija, Éva; Institóris, L.; Kereszty, Éva; Ilisz, I.; Berkecz, R. Metabolomic Characterization of Newest Designer Drugs. Acta Pharm Hung 2021, 91, 185-186.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License